{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:tehran-darou-pharmaceutical-company",
    "identifier": "hg:company:tehran-darou-pharmaceutical-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:17+00:00",
    "name": "Tehran Darou Pharmaceutical Company",
    "slug": "tehran-darou-pharmaceutical-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/tehran-darou-pharmaceutical-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/tehran-darou-pharmaceutical-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/tehran-darou-pharmaceutical-company",
    "summary": "",
    "machine_summary": "Tehran Darou Pharmaceutical Company Tehran Darou Pharmaceutical Company is a Tehran-based pharmaceutical manufacturer with a public joint stock profile and Codal disclosure record under the symbol دتهران. In the Hormuz Group company graph, it matters because it links domestic drug manufacturing, pharmacy supply, therapeutic staples, supplement production, and healthcare access. Its trading or market status requires updated verification, but its manufacturing role remains relevant for understanding Iran's smaller pharmaceutical producers. Tehran Darou is relevant for investors assessing Iran's domestic pharmaceutical manufacturing base, import substitution, drug-supply resilience, and the economics of smaller listed or semi-listed healthcare companies. It can support analysis of common medicine production, regulatory pricing, raw-material import dependence, distributor relationships, and working-capital pressure. Due diligence should verify current trading status, production continuity, licenses, product registrations, raw-material sourcing, receivables, shareholder structure, GMP compliance, and updated financial disclosures before any market or counterparty interpretation. Tehran Darou Pharmaceutical Company manufactures pharmaceutical products including gastrointestinal, nephrology, urology, antipyretic, supplement, oral solid, liquid, suspension, syrup, drop, ointment, capsule, and tablet forms. Its production supports domestic healthcare demand, pharmacy supply, medical distributors, hospital purchasing, and import-substitution pressure in common therapeutic categories. province: Tehran industry: Healthcare & Pharma, Manufacturing, Pharmaceuticals market: Consumer Demand, Healthcare, Materials, Supply Chains challenges: Compliance, Import Dependence, Supply Shortage, Technology Gap company_type: Manufacturer city: Tehran",
    "published_at": "2026-06-28T20:21:36+00:00",
    "modified_at": "2026-06-28T20:21:36+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 3,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/provinces/tehran/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 16,
                "name": "Manufacturing",
                "slug": "manufacturing",
                "url": "https://hormuz.group/industry/manufacturing/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 73,
                "name": "Materials",
                "slug": "materials",
                "url": "https://hormuz.group/market/enterprise-demand/materials/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            },
            {
                "id": 179,
                "name": "Technology Gap",
                "slug": "technology-gap",
                "url": "https://hormuz.group/challenges/market-gaps/technology-gap/"
            }
        ],
        "company_type": [
            {
                "id": 299,
                "name": "Manufacturer",
                "slug": "manufacturer",
                "url": "https://hormuz.group/company-type/manufacturer/"
            }
        ],
        "city": [
            {
                "id": 384,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/cities/tehran/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Tehran",
        "industry": "Healthcare & Pharma, Manufacturing, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Materials, Supply Chains",
        "challenges": "Compliance, Import Dependence, Supply Shortage, Technology Gap",
        "company_type": "Manufacturer",
        "city": "Tehran"
    },
    "fields_summary": {
        "legal_name": "Tehran Darou Pharmaceutical Company Public Joint Stock Company",
        "website": "https://www.tehrandarou.com",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "دتهران",
        "listing_status": "listed_ifb",
        "products_services": "Tehran Darou Pharmaceutical Company manufactures pharmaceutical products including gastrointestinal, nephrology, urology, antipyretic, supplement, oral solid, liquid, suspension, syrup, drop, ointment, capsule, and tablet forms. Its production supports domestic healthcare demand, pharmacy supply, medical distributors, hospital purchasing, and import-substitution pressure in common therapeutic categories.",
        "export_relevance": "low",
        "short_profile": "Tehran Darou Pharmaceutical Company is a Tehran-based pharmaceutical manufacturer with a public joint stock profile and Codal disclosure record under the symbol دتهران. In the Hormuz Group company graph, it matters because it links domestic drug manufacturing, pharmacy supply, therapeutic staples, supplement production, and healthcare access. Its trading or market status requires updated verification, but its manufacturing role remains relevant for understanding Iran's smaller pharmaceutical producers.",
        "investment_relevance": "Tehran Darou is relevant for investors assessing Iran's domestic pharmaceutical manufacturing base, import substitution, drug-supply resilience, and the economics of smaller listed or semi-listed healthcare companies. It can support analysis of common medicine production, regulatory pricing, raw-material import dependence, distributor relationships, and working-capital pressure. Due diligence should verify current trading status, production continuity, licenses, product registrations, raw-material sourcing, receivables, shareholder structure, GMP compliance, and updated financial disclosures before any market or counterparty interpretation."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Tehran Darou Pharmaceutical Company Public Joint Stock Company",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "دتهران",
        "export_relevance": "low",
        "verification_status": "needs_update",
        "data_confidence": "medium",
        "listing_status": "listed_ifb",
        "last_updated": "28/06/2026",
        "website": "https://www.tehrandarou.com",
        "products_services": "Tehran Darou Pharmaceutical Company manufactures pharmaceutical products including gastrointestinal, nephrology, urology, antipyretic, supplement, oral solid, liquid, suspension, syrup, drop, ointment, capsule, and tablet forms. Its production supports domestic healthcare demand, pharmacy supply, medical distributors, hospital purchasing, and import-substitution pressure in common therapeutic categories.",
        "short_profile": "Tehran Darou Pharmaceutical Company is a Tehran-based pharmaceutical manufacturer with a public joint stock profile and Codal disclosure record under the symbol دتهران. In the Hormuz Group company graph, it matters because it links domestic drug manufacturing, pharmacy supply, therapeutic staples, supplement production, and healthcare access. Its trading or market status requires updated verification, but its manufacturing role remains relevant for understanding Iran's smaller pharmaceutical producers.",
        "investment_relevance": "Tehran Darou is relevant for investors assessing Iran's domestic pharmaceutical manufacturing base, import substitution, drug-supply resilience, and the economics of smaller listed or semi-listed healthcare companies. It can support analysis of common medicine production, regulatory pricing, raw-material import dependence, distributor relationships, and working-capital pressure. Due diligence should verify current trading status, production continuity, licenses, product registrations, raw-material sourcing, receivables, shareholder structure, GMP compliance, and updated financial disclosures before any market or counterparty interpretation.",
        "source_note": "Based on public company, official-company, pharmaceutical-sector, market, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 62
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "ticker_symbol": {
            "type": "string",
            "present": true,
            "length": 12
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 3
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 12
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 6
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 27
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 407
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 513
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 648
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 208
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, official-company, pharmaceutical-sector, market, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "needs_update",
        "data_confidence": "medium",
        "last_updated": "28/06/2026",
        "stale_over_180_days": false,
        "quality_score": 80
    },
    "verification": {
        "verification_status": "needs_update",
        "data_confidence": "medium",
        "last_updated": "28/06/2026"
    }
}